baber/WOPTO huggingface dataset:
Patent JP-2921609-B2 (JP)
IPC: D21H17/41
Filed: 1991-01-23
Granted: 1999-07-19
Abstract: In a process for making paper, paperboard and cardboard, paper pulps containing interfering materials are dehydrated in the presence of polymers which, as characteristic constituents, contain copolymerised units of the formulae 
<IMAGE>
 with R<1> and R<2> = H or C1- to C3-alkyl, and have K values of at least 130, the polymers containing less than 10 mol% of units of formula II.
Patent JP-S6051429-B2 (JP)
IPC: C08J5/00
Filed: 1980-01-25
Abstract: In reinforced phenolic resin laminates coated with a surface layer on at least one side, the improvement wherein said surface layer consists essentially of a furan resin coating which is directly bonded to the reinforced phenolic resin laminate, thereby removing surface irregularities in the resultant laminate.
Patent AU-606121-B2 (AU)
Title: Nasal formulations and a process for preparation thereof
Inventor: HANSEN PHILIP EDGAR
IPC: A61K47/24
Filed: 1987-12-15
Granted: 1991-01-31
Abstract: The systemic absorption after intranasal administration of certain drugs, in particular pharmacologically active polypeptides is enhanced in the presence of a phospholipid, such as a phosphalidylcholine (a lecithin), preferably admixed with a vegetable oil.
Patent AU-593721-B2 (AU)
Title: Endovascular stent and delivery system
Inventor: GIANTURCO CESARE
IPC: A61M29/02
Filed: 1988-03-08
Granted: 1990-02-15
Abstract: A wire stent (10) for insertion and expansion into a passageway comprises a plurality of curved sections that are formed into a generally circular configuration. Adjacent curved sections are joined by a bend or cusp (13), so that a series of alternating opposing loops (15, 16) are formed. The wire stent as formed has a cylindrical shape with a longitudinal opening through which a folded balloon catheter is inserted. The opposing loops are tightly contracted about the catheter so that the cylindrical shape has an overlapping region in which portions of adjacent loops longitudinally overlap. The loops are arranged so that when the balloon catheter is inflated, adjacent loops diverge circumferentially relative to each other, thereby decreasing the overlapping region while increasing the diameter of the cylindrical shape (24, 25). As the diameter of the cylindrical shape increases, the wire stent contacts the surface of a passageway in which the stent is inserted. In a method of the present invention, the wire stent (10) is fabricated from a wire formed into a planar serpentine configuration (30). The wire is centered over a semi-cylindrical trough (43) in a flat plate (40) and then pressed into the trough by a forming bar (45) so that a portion of the wire assumes the semi-cylindrical shape. A pulling tool (47), having a hook (47a) at one end, is engaged at the hook with the exposed loops (13) of the serpentine configuration for pulling the exposed loops over the exposed portion of the forming bar to form a generally cylindrical shape from the wire. Once the wire is extracted from the trough and the forming bar is removed, a folded balloon catheter (22) is inserted through the cylindrical shape and the wire is tightly pressed about the catheter.
Patent AU-680332-B2 (AU)
Title: Process and equipment for making thermoplastic containers, such as bottles
Inventor: OUTREMAN JEAN TRISTAN
IPC: B29C49/64
Filed: 1994-12-27
Granted: 1997-07-24
Abstract: The present invention relates to an installation for manufacturing a receptacle from a preform of thermoplastic material, the receptacle being suitable for being subsequently subjected, without significant deformation, to relatively severe temperature conditions encountered during hot-filling or pasteurization processes. The installation includes means for manufacturing a receptacle blank having a hot-shrunk body from the preform, and molding means for forming a final receptacle from the blank. The means for manufacturing a receptacle blank are adapted to form a blank whose shrunk body is longer than the body of the final receptacle to be obtained. The molding means are described in detail.
Patent AU-697208-B2 (AU)
Title: Differential current safety switch
Inventor: BACHL HUBERT
IPC: H02H3/33
Filed: 1995-01-24
Granted: 1998-10-01
Abstract: PCT No. PCT/AT95/00012 Sec. 371 Date Sep. 5, 1996 Sec. 102(e) Date Sep. 5, 1996 PCT Filed Jan. 24, 1995 PCT Pub. No. WO95/20257 PCT Pub. Date Jul. 27, 1995A residual current safety switch has a residual current transformer (3) connected to an evaluation circuit (5) that controls an electromagnetic trigger device (K1) for actuating switching contacts (1, 2). An overvoltage protection circuit (V1), for example designed as a voltage-dependent resistor, is provided. The evaluation circuit (5) and/or the overvoltage protection circuit (V1) are/is connected to terminals that supply them with voltage when the switching contacts (1, 2) are closed through lines (7, 8), with one of the lines extending through the residual current transformer (3) and the other not. The supply current of the electronic components and/or the current that flows through the overvoltage protection circuit (V1) is lower than the triggering current when the nominal voltage is applied.
Patent AU-662341-B2 (AU)
Title: Transdermal therapeutic system
Inventor: BECHER FRANK
IPC: A61M35/00
Filed: 1992-08-20
Granted: 1995-08-31
Abstract: PCT No. PCT/DE88/00370 Sec. 371 Date Apr. 3, 1989 Sec. 102(e) Date Apr. 3, 1989 PCT Filed Jun. 21, 1988 PCT Pub. No. WO89/00437 PCT Pub. Date Jan. 26, 1989.The invention relates to a transdermal therapeutic system for administering or applying active substances to the skin with a backing layer remote from the skin, an active substance depot, an active substance delivery control means controlling the delivery of the active substance through the system and a contact adhesive means for fixing the therapeutic system to the skin, in which the active substance depot is a multichamber system, in which discreet chambers contain one or more active substances.
Patent AU-742281-B2 (AU)
Title: Vaccine composition for herpes simplex virus and methods of using
Inventor: AURELIAN LAURE
IPC: A61K39/245
Filed: 1999-01-15
Granted: 2001-12-20
Abstract: The present invention discloses a new immunogenic composition for Herpes Simplex comprising a whole live HSV-2 virus having the oncogene deleted. Methods of using the vaccine composition are also included.
Patent AU-751688-B2 (AU)
Title: Method for the generation of an electrical signal, sensor device for executing the method and use of the sensor device
Inventor: LANG EDO
IPC: E03D5/10
Filed: 1999-04-13
Granted: 2002-08-22
Abstract: The signal generation method uses a sensor device (10) with a sensor element (12) for detecting a variation in the chemical nature, composition and/or temperature of the fluid within a urinal bowl or aquarium, for providing a signal indicating switching from a passive condition to an active condition when the detected variation in the sensor element output voltage exceeds a threshold value.
Patent AU-574672-B2 (AU)
Title: Water based epoxy compositions
Inventor: DICKINSON PETER
IPC: C08G59/68
Filed: 1984-03-29
Granted: 1988-07-14
Abstract: Aqueous dispersions comprising water, a cationically curable compound, and a photosensitive onium salt, and preferably other ingredients such as sensitizers, fillers, and plasticizers, are useful for making printing screens, lithographic plates, and printed circuit resists. After exposure, the un-cured composition is easily removed by washing with water.
Patent AU-565917-B2 (AU)
Title: Fire-guard
Inventor: RATELBAND JOHANNES BERNADUS
IPC: F24B1/185
Filed: 1984-04-04
Granted: 1987-10-01
Abstract: A fire-guard is provided for heating a room by convection using the heat from a radiation heat source, e.g. a fire place (1), and when the heat source is an open fire for preventing sparks or other small particles of combustion from entering the room in which the fireplace is located. The fire-guard includes a plurality of spaced apart substantially vertical pipes (4), having each at or near their lower end an inlet opening (6) and at or neartheir upper end (7) an outlet opening for air from the room. The portion of the fire-guard extending from its base to a height beyond the inlet openings constitutes a threshold for air flowing from the room towards the heat source. The pipes of at least one pair of adjacent pipes of the fire-guard are hinged together for pivoting aboutthe longitudinal axis of at least one of the said two pipes.
Patent AU-661727-B2 (AU)
Title: Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer
Inventor: MALMROS MARK J
IPC: A61K49/00
Filed: 1992-10-07
Granted: 1995-08-03
Abstract: A biological stain composition contains toluidine blue O and a pharmaceutically acceptable oxidizing agent to convert any leuco toluidine blue O to the chromo form. A dry composition for preparing the stain includes the toluidine blue O, the oxidizing agent and an effervescent agent. These compositions are preferably buffered to improve shelf stability and clinical consistency. Compositions for intra-oral application contain a flavoring agent.
Patent AU-657203-B2 (AU)
Title: Radio telephone
Inventor: KOVANEN JARI
IPC: H04B1/38
Filed: 1993-02-24
Granted: 1995-03-02
Abstract: PCT No. PCT/FI93/00064 Sec. 371 Date Oct. 20, 1993 Sec. 102(e) Date Oct. 20, 1993 PCT Filed Feb. 24, 1993 PCT Pub. No. WO93/17512 PCT Pub. Date Sep. 2, 1993.A radio telephone or the like, comprising including a radio transceiver, a microprocessor circuitry, a work memory, and a reading device in which a removable memory can be inserted to enable reading under control of the microprocessor circuitry, the memory containing the individual data of a radio subscriber and at least the system-specific control parameters of at least one radio telephone system. The microprocessor circuitry configures the radio telephone to operate in the radio telephone system by means of the parameters. The removable memory contains essentially the entire software of the radio telephone including the control parameters, and the non-volatile program memory of the radio telephone contains only the loading routine for loading the software including the control parameters into the work memory when the radio telephone is switched on or the removable memory is inserted in the reading device.
Patent AU-566560-B2 (AU)
Title: Pyridine-2-(thio)ethers
Inventor: SCHEFFLER GERHARD
IPC: C07D401/12
Filed: 1984-12-20
Granted: 1987-10-22
Abstract: There are disclosed pyridine-2-ethers and pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring corresponding to the formula    <IMAGE>  I  the pyridine-N-oxides and/or amine oxides thereof and the pharmaceutically acceptable salts thereof. The compounds show analgesic activity.
Patent AU-557131-B2 (AU)
Title: Epoxy resin composition and process for preparing laminates therefrom
Inventor: KOENIG RAYMOND
IPC: H05K1/03
Filed: 1985-01-30
Granted: 1986-12-04
Abstract: An epoxy resin composition and a process for preparing electrical laminates therefrom has been disclosed. 
<??>The epoxy resin composition is comprised of an epoxy resin, a solvent and a hardener which is the reaction product of a hexa-alkyl ether of a methylol melamine having the general formula: 
<CHEM>
 wherein each R, independently, is an alkyl radical having from 1 to 4 carbon atoms with a polyhydric phenol and, optionally, a monohydric phenol, with the phenol compound(s) having been employed in an amount to provide a ratio of at least one reactive phenolic hyxroxy group for each alkoxy group.
Patent AU-768537-B2 (AU)
Title: Formulation comprising testosteron undecanoate and castor oil
Inventor: DE HENRIK NIJS
IPC: A61K9/48
Filed: 2000-03-27
Granted: 2003-12-18
Abstract: Disclosed is a pharmaceutical formulation in the form of a capsule for oral administration comprising testosterone undecanoate as an active ingredient dissolved in a pharmaceutically acceptable liquid carrier, characterised in that the liquid carrier comprises at least 50 % by weight of castor oil. The choice of castor oil as the liquid carrier, in conjunction with the choice of testosterone undecanoate as the androgen, makes for a solution which can comprise about 200-250 mg/ml of TU. This is a novel achievement for any orally administerable solution of testosterone. The solution may also contain a lipophilic surfactant such as lauroglycol.
Patent AU-670295-B2 (AU)
Title: Quinuclidine derivatives as squalene synthetase inhibitors
Inventor: MALLION KEITH BLAKENEY
IPC: A61P9/10
Filed: 1993-06-02
Granted: 1996-07-11
Abstract: PCT No. PCT/GB93/01165 Sec. 371 Date Jun. 9, 1994 Sec. 102(e) Date Jun. 9, 1994 PCT Filed Jun. 2, 1993 PCT Pub. No. WO93/24486 PCT Pub. Date Dec. 9, 1993Quinuclidine derivatives of formula I, and their pharmaceutically acceptable salts,   <IMAGE>   in which R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 are joined together so that CR1-CR2 is a double bond; Ar1 is a phenylene moiety; Ar2 is a 6-membered heteroaryl moiety containing one or two nitrogen atoms; and wherein one or both of Ar1 and Ar2 may optionally bear one or more substituents such as halogeno, hydroxy, amino, nitro, cyano, carboxy, carbamoyl, alkyl, alkenyl, alkynyl, alkoxy, alkylamino, di-alkylamino, N-alkylcarbamoyl, di-N,N-alkylcarbamoyl, alkoxycarbonyl, alkylthio, alkylsulphinyl, alkylsulphonyl, halogenoalkyl, alkanoylamino, alkylenedioxy, alkanoyl and oxime derivatives thereof and O-alkyl ethers of said oxime derivatives; inhibit squalene synthase and are therefore useful in treating treating diseases and medical conditions where inhibition of squalene synthase is desirable, for example in treating hypercholesterolemia and atherosclerosis. Processes for the preparation of these derivatives and pharmaceutical compositions containing them are also referred to as well as their use in medicine.
Patent AU-703246-B2 (AU)
Title: 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
Inventor: IV SIEGFRIED B CHRISTENSEN
IPC: A61K31/505
Filed: 1995-12-21
Granted: 1999-03-25
Abstract: The present invention relates to novel 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).
Patent AU-576000-B2 (AU)
Title: Flat yarn
Inventor: DAMHORST HUBERT
IPC: D01D5/16
Filed: 1985-09-25
Granted: 1988-08-11
Abstract: A method of producing a flat polymeric yarn is disclosed which includes the steps of melt spinning a polymer to form a plurality of running filaments, combining the filaments to form a running bundle of filaments, and then guiding the running bundle into contact with a ribbon of fluid so as to apply a controlled quantity of the fluid to the bundle. The fluid coated bundle is guided over a plurality of serially arranged curved braking surfaces, and it is then withdrawn by means of a draw roll so as to draw the running bundle to an extent which exceeds its plastic limit. The application of the fluid to the bundle in accordance with the present invention results in a hydrodynamic friction, rather than a sliding contact friction, between the bundle and braking surfaces, and produces yarn of very uniform quality while also avoiding wear of the braking surfaces.
Patent AU-662079-B2 (AU)
Title: Antiarrhythmic and cardioprotective substituted- 1(2H)isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
Inventor: LAL BANSI DR
IPC: C07D413/12
Filed: 1993-09-27
Granted: 1995-08-17
Abstract: Described are guanidinocarbonyl isoquinolines I, <CHEM> with R(1) hydrogen, (amino)(cyclo)(aryl)alk(en)yl, (heteroaryl); R(2) hydrogen, halogen, alkyl, or Aryl; G <CHEM> X(2), X(3) and X(4) hydrogen, halogen, nitro, amino, alkyl, sulfonamide, (mono)(di)(lower alkyl)(amino), benzyloxy, hydroxy; X(1) hydrogen, oxygen, sulfur and NR(7)R(8), and their pharmaceutically acceptable salts; described is also the process for their prepara-tion, their use as medicaments, and medicaments containing them for treating congestive heart failure, arrhythmic conditions as well as cardioprotective agents in mammals.
Patent AU-767272-B2 (AU)
Title: Glue wheel
Inventor: GARRETT JIMMY R
IPC: B31B50/00
Filed: 2000-07-20
Granted: 2003-11-06
Abstract: A glue wheel (10) for use with a glue shoe (14) in applying a pattern of cold glue to a receiving surface (18) such as a glue flap. The glue wheel (10) has a rim (28) with recessed, glue-holding, structures (30) flanked by smooth side sections (32) for sealing engagement with the glue shoe (14). There are a pair of circumferential grooves (42) through the glue-holding structures (30) adjacent the smooth side sections (32) and the cold glue is metered by the glue shoe (14) over the glue-holding structures (30).  <IMAGE>
Patent AU-583861-B2 (AU)
Title: Nautical vehicle
Inventor: GARCIA MANUEL MARTIN
IPC: B63H16/18
Filed: 1985-10-29
Granted: 1989-05-11
Abstract: Nautical vehicle consisting of a central, tubular body (1) of fibre glass, hermetically sealed with a streamlined bow (2) in front and a bevelled zone at the back in the lower half which gives way to a keel. The upper plane of the vehicle has a longitudinal slot containing a seat (22). There are provided extending dismountable arms (23) at each side at the end of which are floats (24). In front of the seat (22) are provided a couple of pedals (9) connected via a cardan transmission and a reversing mechanism to a propeller.
Patent AU-674700-B2 (AU)
Title: Paper pallet
Inventor: LIM CHOW PAK
IPC: B65D19/34
Filed: 1993-11-09
Granted: 1997-01-09
Abstract: There is disclosed a paper pallet comprising of a first sheet (10), a second sheet (20) and support means (30), wherein the support means (30) is part of the first sheet (10) and second sheet (20) formed by cutting, creasing, folding and securing tongues (35,37). The tongue (35) intersects at a 90 degree angle with the tongue (37) and a flange (32) is secured to the slot (34) which forms "slot in" locking means. the strength of the present invention can be further increased by adding a reinforcement core (36) to the inside of the hollow space within the support means (30) or alternatively the reinforcement core (36) may enclose the fastened tongues (35,37) to form the support means (30). The invention can be varied in dimension, height and numbers of the support means (30). <IMAGE>
Patent AU-630928-B2 (AU)
Title: A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
IPC: C07B55/00
Filed: 1990-02-15
Granted: 1992-11-12
Abstract: A process for the optical resolution of racemic 1,4-dihydropyridines, containing isothioureido groups. Salification of racemic isothioureas with optically active acids produces diasteroisomeric mixtures of isothiouronium salts, that, using conventional techniques, are separated in the individual components to give optically pure isothioureides of 1,4-dihydropyridines and salts thereof with conventional acids. Said optically pure 1,4-dihydropyridines can then be subjected to desulphuration and to different transformations to give other enantiomerically pure and therapeutically useful 1,4-dihydropyridines.
Patent AU-654788-B2 (AU)
Title: Network control system and timer manager therefor
Inventor: WOEST KAREN L
IPC: H04L29/06
Filed: 1994-01-31
Granted: 1994-11-17
Abstract: A network control system for use in a communication network controls the receipt and transmission of messages between at least a pair of nodes of the network. Messages conveyed within the network include short messages having a length less than a predetermined number of bytes and long messages having a length greater than the predetermined number of bytes. The network control system is located at least at one of the nodes and includes a connectionless network control portion for controlling the transmission and receipt of the short messages and a connection-oriented network control portion coupled to the connectionless network control portion for establishing a connection with the other node for controlling the transmission and receipt of the long messages between the pair of nodes. The connectionless portion of the system includes a transport stage which provides end-to-end reliability within the system, a network stage for establishing routing of the messages, and a data link stage for providing point-to-point reliability and other control functions such as message flow control, node resynchronization, and node suspension. The connection-oriented portion of the system includes a session stage for handling the communication of long messages greater then the predetermined number of bytes in length.
Patent AU-595204-B2 (AU)
Title: Centrifugal elastomer elastomeric impellers and vane core extraction for making same
Inventor: HYLL JOHN
IPC: B29C45/44
Filed: 1986-06-10
Granted: 1990-03-29
Abstract: An elastomeric-covered shrouded impeller, having a pair of disk-like shrouds (16, 17) enclosing vanes and vane passages, which has an improved throat opening (10) having sweeping internal sidewalls is disclosed. A three-piece mold core (A,B,C) is utilized to form the vane passage and the sweeping curved throat inlet of the impeller.
Patent AU-725696-B2 (AU)
Title: Bicyclic inhibitors of protein farnesyl transferase
Inventor: DOBRUSIN ELLEN M
IPC: A61K31/4164
Filed: 1998-02-11
Granted: 2000-10-19
Abstract: PCT No. PCT/US98/03025 Sec. 371 Date Aug. 2, 1999 Sec. 102(e) Date Aug. 2, 1999 PCT Filed Feb. 11, 1998 PCT Pub. No. WO98/34921 PCT Pub. Date Aug. 13, 1998The present invention provides compounds of Formula (I). The present invention also provides a method of treating cancer and treating or preventing restenosis or atherosclerosis. Also provided by the present invention is a pharmaceutically acceptable composition containing a compound of Formula (I).
Patent AU-672901-B2 (AU)
Title: Process for the catalytic partial oxidation of hydrocarbons
Inventor: JACOBS LUDOVICUS LEONARDUS GER
IPC: C01B32/40
Filed: 1994-06-16
Granted: 1996-10-17
Abstract: A process for the catalytic partial oxidation of a hydrocarbon feedstock comprises contacting a feed comprising a hydrocarbon feedstock and an oxygen-containing gas at elevated pressure and a temperature of at least 950 DEG C with a catalyst comprising as a catalytically active metal rhodium, iridium or ruthenium.
Patent AU-543797-B2 (AU)
Title: Pharmaceutically active 9-chloroprostaglandins
Inventor: SKUBALLA WERNER
IPC: C07C405/00
Filed: 1980-12-09
Granted: 1985-05-02
Abstract: Compounds of the formula   <IMAGE>   wherein the 9-chlorine atom can be in the  alpha - or  beta -position, R1 is OR2, or NHR3 wherein R3 is H or the acyl group of a C1-15 hydrocarbon carboxylic or sulfonic acid; A is -CH2-CH2- or cis-CH=CH-, B is -CH2-CH2-,trans-CH=CH-, or -C 3BOND C-,   <IMAGE>   wherein the OH-group in each case can be in the  alpha - or  beta -position, and can be etherified or esterified by tetrahydropyranyl, tetrahydrofuranyl,  alpha -ethoxyethyl, trimethylsilyl dimethyl, tert-butylsilyl, tribenzylsilyl, acetyl, propionyl, butyryl or benzoyl; D and E together represent a direct bond or D is a straight-chain or branched alkylene group of 1-10 carbon atoms, optionally substituted by fluorine, and E is oxygen or sulfur or a direct bond, and R4 is hydroxy or hydroxy etherified or esterified as defined for W above; R5 is a C1-10 hydrocarbon aliphatic group; a C1-10 hydrocarbon, aliphatic group substituted by aryl, a substituted aryl as defined for R2 above, or halogen; or cycloalkyl, substituted cycloalkyl, aryl, substituted aryl or aromatic heterocyclic, all as defined for R2 above; or a physiologically acceptable salt thereof with a base when R1 is OH, have valuable pharmacological properties.